𝔖 Bobbio Scriptorium
✦   LIBER   ✦

'Emancipated' biotechs offer new drugs for neurodegeneration

✍ Scribed by Basu, Paroma

Book ID
109929557
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
128 KB
Volume
9
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Glycogen synthase kinase 3 (GSK-3) inhib
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
✍ Ana Martinez; Ana Castro; Isabel Dorronsoro; Mercedes Alonso πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 135 KB

Glycogen synthase kinase 3 (GSK-3) was initially described as a key enzyme involved in glycogen metabolism, but is now known to regulate a diverse array of cell functions. Two forms of the enzyme, GSK-3alpha and GSK-3beta, have been previously identified. Small molecules inhibitors of GSK-3 may, the

ChemInform Abstract: Glycogen Synthase K
ChemInform Abstract: Glycogen Synthase Kinase 3 (GSK-3) Inhibitors as New Promising Drugs for Diabetes, Neurodegeneration, Cancer, and Inflammation
✍ Ana Martinez; Ana Castro; Isabel Dorronsoro; Mercedes Alonso πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 25 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v